Information Provided By: 
Fly News Breaks for August 25, 2017
SPLK
Aug 25, 2017 | 08:13 EDT
Canaccord analyst Richard Davis raised his price target on Splunk to $80 from $75 following solid Q2 results. The analyst said the company has executed well, has built a valuable franchise and remains undervalued. Davis believes the company is well positioned and statistically inexpensive and reiterated his Buy rating on Splunk shares.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
